Risperidone Effectiveness of Improvement Cognitive Function in Mini Mental State Examination and Clock Drawing Test in Schizophrenic Patients

Abstract

Risperidone is a second-generation antipsychotic medications that can significantly improve cognitive function in schizophrenic patients. The objective of the present study is to determine the effectiveness of risperidone on cognitive function for improving the Mini Mental State Examination( MMSE) and  Clock Drawing Test (CDT) scores. A total of 30 samples of schizophrenic patients who received risperidone treatment (27 men and 3 women), attending the outpatient in mental health hospital in Sumatera Utara, autoanamnese undergo direct interview using a measurement scale BPRS then undergo examination MMSE and CDT scores, the study was conducted for 8 weeks (pre and post test). From this study found that the risperidone effectively improves cognitive function in schizophrenic patients based on the presence of significant differences in MMSE and CDT scores (p = 0.0001).

Keywords: MMSE and CDT scores, risperidone, schizophrenia